HIGHLIGHTS
- who: Immune-Inflammation Index Can et al. from the Department of Gynecology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China have published the research: Pretreatment Systemic Immune-In fl ammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB, in the Journal: (JOURNAL)
- what: In this study, the SII in patients with cervical cancer who underwent NACT was evaluated as an indicator for treatment response, and the association between the SII and patient survival was also . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.